FEB 25, 2018
CORONIS NEUROSCIENCES RECEIVES FDA ORPHAN DRUG DESIGNATION FOR DAVUNETIDE
MARCH 22, 2017 - PRESS RELEASE
DETAILED DEVELOPMENTAL CASE STUDY OF PREVELENT ADNP MUTATION: A STORY FOCUSED ON P.TYR719* FOR IMPROVING DIAGNOSTIC PROCEDURES, PHENOTYPIC SCOPE AND INTERVENTIONS (ALEXI'S 8.5 YEAR JOURNEY)
FEB 22, 2017 - PRESS RELEASE (ASD sites)
NEW STUDY LINKS BABY-TEETH AS A UNIQUE BIOMARKER FOR SYNDROME HIGHLY LINKED TO AUTISM
FEB 21, 2017 - PRESS RELEASE:
NEWLY-IDENTIFIED DIAGNOSTIC BIOMARKER LINKED TO ONE OF THE TOP AUTISM-RELATED SYNDROMES SEEN IN CHILDREN BEFORE THEIR FIRST BIRTHDAY:  PREMATURE PRIMARY TOOTH ERUPTION IN ADNP-MUTATED CHILDREN.

HOME. ABOUT. RESEARCH. SUPPORT-US. PRIVACY-POLICY. ADNP SYNDROME. ADNP GENE. SYNDROME PHENOTYPE.


All rights reserved. No portion of the content of this website may be reproduced in any manner without the written permission of the author/creator.   Any information used from this website must also have credit noted to ADNP Kids Research Foundation / www.adnpfoundation.org. The information on this website is not substitute for personal diagnosis or medical care advise. Families and patients should consult a medically qualified clinician in all matters relating to genetic diagnosis, management and health. Information on ADNP changes is a very fast-moving field and while the information in this guide is believed to be the best available at the time of publication, some facts may later be updated or change. Please see additional disclosures on our PRIVACY POLICY page.

    If you have any comments or questions please contact us here